Oct 15, 2025
The move to end research into a potential type 1 diabetes cure has left many people with diabetes frustrated, reflective, and still holding on to hope.
Oct 14, 2025
The FDA has accepted MannKind’s application to expand the use of its inhaled insulin, Afrezza, to children, marking a key step toward potential pediatric approval.
Oct 7, 2025
Biolinq’s Shine biosensor uses needle-free technology and real-time LED feedback to track glucose for people with type 2 diabetes.
Roche’s latest integration brings AI-driven glucose predictions, personalized logging, and easy data sharing into one connected platform.
Sep 30, 2025
FDA clears Tandem’s t:slim X2 insulin pump for use with Lilly’s ultra-rapid Lyumjev insulin, expanding options beyond Humalog and Novolog.
Sep 25, 2025
We got an early look the upcoming Trends tab coming to Dexcom G7, which brings food, exercise, insulin, and glucose data into one dashboard — rolling out soon in the U.S.
Sep 24, 2025
We got a first look at the FDA-cleared 7-day SteadiSet infusion set coming to all Tandem pumps in the U.S next year.
Sep 15, 2025
This continuous glucose monitor promises multi-sensor health tracking and is aiming for a mid-2026 launch
Sep 4, 2025
The latest Series A funding brings Luna's bedtime patch pump, for MDI users, one step closer to reality.
